Advanced Pancreatic Cancer Treatment in China"We want to uncover the ultimate laws governing the true occurrence and development of pancreatic cancer and completely transform the treatment outcomes fo...
On December 4, 2024, the Food and Drug Administration granted accelerated approval to zenocutuzumab-zbco (Bizengri, Merus N.V.) for use in adults with specific conditions.Patients with advanced, unr...
Understanding pancreatic cancerPancreatic cancer is recognized as one of the most aggressive and lethal cancers, largely due to the fact that it tends to be diagnosed at a late stage. The pancreas, a ...
Pancreatic cancer Pancreatic cancer, also referred to as the "king of cancers," is a highly deadly malignant tumor, with a survival rate of fewer than 10% over a 5-year period. As a result of inadequ...
The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pa...
Adolescent obesity is associated with many health problems in later life, and a large Israeli study has shown that the increased risk of fatal pancreatic cancer is one of them. For more than 20 y...
The survival rate of pancreatic cancer is very low. In the past 40 years, the survival rate has not changed significantly. Finding effective treatments is an urgent challenge for researchers. For man...
Specific molecular signals released by pancreatic cancer cells have been determined. Pancreatic cancer is usually detected after the disease has spread, and chemotherapy often has no effect on slowin...
In a recent interview, Dr. Afsaneh Barzi, assistant professor of clinical medicine at the University of Southern California Norris Comprehensive Cancer Center, told you about existing and emerging new...
New research has found that pancreatic cancer cells rely heavily on a protein to grow and spread. The research results can bring new treatment and prevention strategies for pancreatic cancer.The Amer...